Drug:
Reaction: PRODUCT DOSE OMISSION ISSUE
20260101 - 20261231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 26940079 |
AU |
||
Device deployment issue, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 2 | 26940092 |
US |
75 | 2 |
Needle issue, Accidental exposure to product, Device leakage, Feeling abnormal, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 3 | 26940254 |
US |
69 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 4 | 26940273 |
AU |
2 | |
Device deployment issue, Product dose omission issue, |
||||
GOLIMUMAB, |
||||
| 5 | 26940297 |
US |
||
Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 6 | 26940313 |
US |
66 | 2 |
Dry mouth, Somnolence, Illness, Abdominal discomfort, Headache, Nausea, Dyspnoea, Fatigue, Product administered at inappropriate site, Product dose omission issue, |
||||
ABALOPARATIDE, ROSUVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CETIRIZINE HYDROCHLORIDE, SPIRONOLACTONE, NETARSUDIL AND LATANOPROST OPHTHALMIC SOLUTION, 0.02%/0.005%, |
||||
| 7 | 26940326 |
US |
2 | |
Feeling abnormal, Dizziness, Product dose omission issue, Product colour issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 8 | 26940337 |
US |
58 | |
Infection, Abscess, Eczema, Product dose omission issue, |
||||
| 9 | 26940339 |
US |
1 | |
Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 10 | 26940340 |
US |
53 | 2 |
Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
| 11 | 26940358 |
US |
2 | |
Spinal stenosis, Injection site bruising, Pain in extremity, Headache, Pain, Bone pain, Product dose omission issue, Extra dose administered, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CYCLOBENZAPRINE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 12 | 26940361 |
US |
2 | |
Adverse drug reaction, Rash, Fatigue, Headache, Needle issue, Needle issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, ERGOCALCIFEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN C, CYANOCOBALAMIN, BUPROPION, ALPRAZOLAM, SERTRALINE, |
||||
| 13 | 26940382 |
US |
2 | |
Injection site discomfort, Chest pain, Pain in jaw, Urine odour abnormal, Anxiety, Injection site pain, Injection site reaction, Injection site bruising, Dizziness, Headache, Arthralgia, Bone pain, Product distribution issue, Product dose omission in error, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, TOPIRAMATE, |
||||
| 14 | 26940391 |
US |
2 | |
Adverse event, Headache, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 15 | 26940406 |
US |
81 | 1 |
Drug delivery system malfunction, No adverse event, Product dose omission issue, |
||||
TOCILIZUMAB, |
||||
| 16 | 26940430 |
US |
2 | |
Injection site urticaria, Muscle spasms, Pain in extremity, Injection site pruritus, Nausea, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, BICTEGRAVIR SODIUM, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE FUMARATE, GABAPENTIN, LISINOPRIL, PYRIDOSTIGMINE BROMIDE, |
||||
| 17 | 26940476 |
US |
2 | |
Abdominal discomfort, Heart rate increased, Nausea, Headache, Palpitations, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 18 | 26940524 |
US |
2 | |
Nodule, Dizziness, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 19 | 26940560 |
US |
2 | |
Knee operation, Injection site haematoma, Constipation, Injection site bruising, Injection site erythema, Palpitations, Incorrect dose administered, Off label use, Product dose omission issue, Product administration interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, CELECOXIB, STANDARDIZED SENNA CONCENTRATE AND DOCUSATE SODIUM, |
||||
| 20 | 26940588 |
US |
2 | |
Product dose omission issue, Product availability issue, |
||||
ABALOPARATIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FLUOXETINE HYDROCHLORIDE, HYDROXYZINE, MELOXICAM, PREGABALIN, ROPINIROLE, |
||||
| 21 | 26940619 |
US |
2 | |
Upper limb fracture, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 22 | 26940620 |
US |
2 | |
Tinnitus, Muscular weakness, Chest pain, Hypoaesthesia, Paraesthesia, Headache, Dizziness, Fatigue, Product dose omission issue, |
||||
ABALOPARATIDE, ROSUVASTATIN, |
||||
| 23 | 26940665 |
US |
1 | |
Injection site reaction, Therapy interrupted, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 24 | 26940681 |
US |
44 | 2 |
Uterine leiomyoma, Product dose omission issue, |
||||
ASFOTASE ALFA, ASFOTASE ALFA, |
||||
| 25 | 26940685 |
US |
||
Keratomileusis, Visual impairment, Product dose omission issue, Corrective lens user, Wrong technique in product usage process, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 26 | 26940715 |
US |
2 | |
Influenza like illness, Unevaluable event, Dizziness, Heart rate increased, Back pain, Injection site bruising, Arthralgia, Headache, Fatigue, Product dose omission issue, Intentional dose omission, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 27 | 26940747 |
US |
2 | |
Dysgeusia, Heart rate increased, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 28 | 26940809 |
US |
2 | |
Abdominal discomfort, Constipation, Palpitations, Fatigue, Asthenia, Cardiac disorder, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FLUOXETINE HYDROCHLORIDE, GABAPENTIN, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM, MELATONIN, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, PREDNISONE, TIOTROPIUM BROMIDE, ERGOCALCIFEROL, |
||||
| 29 | 26940825 |
US |
2 | |
Abdominal discomfort, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 30 | 26940855 |
US |
81 | 2 |
Muscle twitching, Vulvovaginal discomfort, Product dose omission issue, |
||||
ABALOPARATIDE, THYROID, PORCINE, |
||||
| 31 | 26940891 |
US |
2 | |
Dyspnoea, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, AMBRISENTAN, FAMOTIDINE, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), RIFAXIMIN, MAGNESIUM, AIRBORNE, FUROSEMIDE, AZELASTINE HYDROCHLORIDE, AZELASTINE, TADALAFIL, ALBUTEROL SULFATE, ROSUVASTATIN, ALPRAZOLAM, OXYGEN, 0XYGEN, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, COLESTIPOL HYDROCHLORIDE, DIGOXIN, ONDANSETRON HYDROCHLORIDE, ZOLPIDEM TARTRATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, |
||||
| 32 | 26940978 |
GB |
61 | |
Rheumatoid arthritis, Product prescribing issue, Product dose omission issue, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 33 | 26940979 |
US |
2 | |
Urinary tract infection, Headache, Dizziness, Nausea, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 34 | 26940986 |
US |
2 | |
Presyncope, Paraesthesia, Brain fog, Sensory disturbance, Injection site discomfort, Upper-airway cough syndrome, Respiratory tract infection, Nasopharyngitis, Vertigo, Dizziness, Muscle spasms, Nausea, Headache, Fatigue, Injection site pain, Injection site bruising, Constipation, Abdominal pain upper, Abdominal distension, Malaise, Pain in extremity, Diarrhoea, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ROSUVASTATIN, |
||||
| 35 | 26941011 |
US |
2 | |
Abdominal distension, Weight increased, Constipation, Malaise, Nausea, Vomiting, Diarrhoea, Dizziness, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 36 | 26941040 |
US |
75 | 2 |
Oropharyngeal pain, Productive cough, Fall, Tooth fracture, Device defective, Product dose omission issue, Device issue, Injury associated with device, |
||||
ABALOPARATIDE, |
||||
| 37 | 26941063 |
US |
1 | |
Product distribution issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 38 | 26941065 |
US |
1 | |
Somnolence, Fatigue, Abdominal pain upper, Diarrhoea, Product dose omission issue, Product dose omission in error, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 39 | 26941072 |
US |
2 | |
Migraine, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 40 | 26941082 |
US |
2 | |
Myalgia, Brain fog, Disturbance in attention, Feeling abnormal, Dizziness, Arthralgia, Muscle spasms, Fatigue, Back pain, Headache, Nausea, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, CALCIUM, FAMOTIDINE, PANTOPRAZOLE, ROSUVASTATIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 41 | 26941095 |
US |
36 | |
Dermatitis atopic, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 42 | 26941099 |
US |
2 | |
Vitamin D deficiency, Blood pressure fluctuation, Feeling abnormal, Tachycardia, Blood pressure increased, Heart rate increased, Palpitations, Injection site pain, Injection site bruising, Headache, Accidental overdose, Product dose omission issue, Circumstance or information capable of leading to medication error, |
||||
ABALOPARATIDE, |
||||
| 43 | 26941117 |
US |
70 | 2 |
Somnolence, Blood pressure decreased, Fatigue, Device failure, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 44 | 26941133 |
US |
2 | |
Abdominal hernia, Injection site pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, CELECOXIB, |
||||
| 45 | 26941174 |
US |
2 | |
Spinal pain, Paraesthesia, Cardiovascular symptom, Grip strength decreased, Injection site urticaria, Purpura, Blood pressure increased, Heart rate increased, Dizziness, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 46 | 26941175 |
US |
2 | |
Scoliosis, Fall, Dyspnoea, Device issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 47 | 26941177 |
US |
38 | 1 |
Product temperature excursion issue, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 48 | 26941224 |
CN |
1 | |
Device deployment issue, Product dose omission issue, Accidental exposure to product, |
||||
GOLIMUMAB, |
||||
| 49 | 26941330 |
RU |
2 | |
Device defective, Off label use, Product dose omission issue, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 50 | 26941340 |
US |
||
Gastrointestinal disorder, Abdominal distension, Menstruation irregular, Product dose omission issue, |
||||
NORGESTIMATE AND ETHINYL ESTRADIOL, |
||||
| 51 | 26941386 |
US |
54 | |
Product dose omission issue, |
||||
EPTINEZUMAB-JJMR, |
||||
| 52 | 26941398 |
US |
2 | |
Device defective, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 53 | 26941461 |
US |
2 | |
Anxiety, Chest pain, Heart rate increased, Dizziness, Fatigue, Headache, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NAPROXEN, NAPROXEN SODIUM, FLUOXETINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, VITAMIN E, |
||||
| 54 | 26941464 |
US |
59 | 2 |
Myalgia, Nausea, Heart rate increased, Headache, Bone pain, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, TEMAZEPAM, ERGOCALCIFEROL, |
||||
| 55 | 26941475 |
US |
2 | |
Constipation, Dizziness, Irritable bowel syndrome, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, MAGNESIUM, POLYETHYLENE GLYCOL 3350, VITAMIN C, |
||||
| 56 | 26941486 |
US |
2 | |
Illness, Fatigue, Lethargy, Therapeutic response unexpected, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 57 | 26941515 |
US |
2 | |
Hypoacusis, Decreased appetite, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 58 | 26941524 |
KH |
2 | |
Cholelithiasis, Chronic myeloid leukaemia, Malignant neoplasm progression, Vaginal haemorrhage, Uterine haemorrhage, Haematochezia, Hypothyroidism, Malaise, Diabetes mellitus, Loose tooth, Blood creatinine decreased, Varicose vein, Drug intolerance, Cardiac disorder, Crying, Transferrin saturation decreased, Blood cholesterol increased, Microalbuminuria, White blood cell count increased, Prothrombin time shortened, Blood lactate dehydrogenase abnormal, Lymphocyte count abnormal, Antinuclear antibody positive, Blood triglycerides increased, Product dose omission issue, Iron deficiency anaemia, Alanine aminotransferase abnormal, Aspartate aminotransferase abnormal, Manganese increased, Neutrophil count increased, Mean cell haemoglobin concentration abnormal, Neck pain, Back pain, Pallor, Ocular hyperaemia, Pain, Peripheral swelling, Oedema peripheral, Normochromic normocytic anaemia, Hepatomegaly, Dyslipidaemia, Hyperglycaemia, Hepatic steatosis, Arthralgia, Pain in extremity, Chest pain, Haemoglobin decreased, Anaemia, Dyspnoea, Anxiety, Tachycardia, White blood cell count abnormal, Cough, Blood pressure increased, Blood iron decreased, Cytogenetic analysis abnormal, Hypertension, Depression, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, NILOTINIB, DICLOFENAC, DICLOFENAC SODIUM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, CALCIUM, |
||||
| 59 | 26941568 |
US |
48 | 1 |
Needle issue, Product dose omission issue, Accidental exposure to product, |
||||
GUSELKUMAB, |
||||
| 60 | 26941573 |
US |
43 | |
Dermatitis atopic, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 61 | 26941595 |
US |
2 | |
Pyrexia, Dizziness, Injection site reaction, Diarrhoea, Pain, Insomnia, Pain in extremity, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, GLIMEPIRIDE, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, MIRABEGRON, PIOGLITAZONE, PREGABALIN, TERBINAFINE HYDROCHLORIDE, TERBINAFINE, TERBINAFINE HYDROCHLORIDE TABLET, |
||||
| 62 | 26941599 |
US |
2 | |
Adverse event, Heart rate increased, Liquid product physical issue, Product dose omission issue, Product use issue, Device failure, |
||||
ABALOPARATIDE, |
||||
| 63 | 26941600 |
US |
2 | |
Gingival abscess, Headache, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, |
||||
| 64 | 26941602 |
US |
64 | 2 |
Impaired driving ability, Condition aggravated, Fall, Dizziness, Fatigue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 65 | 26941605 |
US |
61 | 2 |
Sinus headache, Urinary tract infection, Feeling abnormal, Dizziness, Fatigue, Palpitations, Product dose omission issue, Product administered at inappropriate site, |
||||
ABALOPARATIDE, ABALOPARATIDE, CARVEDILOL, CYANOCOBALAMIN, SPIRONOLACTONE, |
||||
| 66 | 26941621 |
US |
81 | 2 |
Product dose omission issue, |
||||
MAVACAMTEN, |
||||
| 67 | 26941622 |
US |
2 | |
Biopsy skin, Wound, Back pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, EVOLOCUMAB, ROSUVASTATIN, |
||||
| 68 | 26941640 |
US |
2 | |
Fat tissue increased, Injection site mass, Hypotension, Swelling, Abdominal distension, Dizziness, Headache, Injection site reaction, Heart rate increased, Blood calcium increased, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, ERGOCALCIFEROL, |
||||
| 69 | 26941681 |
US |
2 | |
Injury corneal, Paraesthesia, Dizziness, Arthralgia, Bone pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 70 | 26941719 |
US |
79 | |
Injection site haemorrhage, Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 71 | 26941742 |
US |
||
Manufacturing product shipping issue, Product dose omission issue, No adverse event, Product packaging issue, Product physical issue, Product container seal issue, |
||||
SITAGLIPTIN, |
||||
| 72 | 26941749 |
US |
2 | |
Hospitalisation, Emergency care, Spinal pain, Musculoskeletal pain, Injection site pain, Product dose omission issue, Product use issue, |
||||
ABALOPARATIDE, |
||||
| 73 | 26941790 |
US |
2 | |
Muscular weakness, Muscle spasms, Pain in extremity, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 74 | 26941793 |
US |
2 | |
Foot fracture, Bone development abnormal, Heart rate increased, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 75 | 26941821 |
US |
82 | |
Device malfunction, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 76 | 26941823 |
US |
2 | |
Muscle twitching, Somnolence, Dizziness postural, Nocturia, Orthostatic hypertension, Depressed mood, Depression, Amnesia, Pollakiuria, Mood altered, Decreased appetite, Fatigue, Palpitations, Heart rate increased, Dizziness, Diarrhoea, Insomnia, Asthenia, Arthralgia, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, |
||||
| 77 | 26941834 |
US |
2 | |
Intentional product use issue, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 78 | 26941835 |
US |
2 | |
Dyspepsia, Crepitations, Palpitations, Injection site pain, Wrong technique in product usage process, Product dose omission issue, Product communication issue, |
||||
ABALOPARATIDE, SIMVASTATIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 79 | 26941837 |
US |
2 | |
Adverse drug reaction, Product dose omission issue, |
||||
ABALOPARATIDE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, CALCIUM, FOLIC ACID, OXYBUTYNIN, VALSARTAN, VALSARTAN ORAL, CYANOCOBALAMIN, |
||||
| 80 | 26941886 |
US |
2 | |
Spinal pain, Headache, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 81 | 26941894 |
US |
2 | |
Contusion, Injection site pain, Product dose omission issue, Product use issue, |
||||
ABALOPARATIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, |
||||
| 82 | 26941901 |
US |
64 | 2 |
Hypertension, Pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 83 | 26941904 |
AE |
2 | |
Rheumatoid arthritis, Product dose omission issue, Therapy interrupted, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, |
||||
| 84 | 26941909 |
US |
28 | 2 |
Product dose omission issue, Product complaint, |
||||
MEPOLIZUMAB, |
||||
| 85 | 26941935 |
US |
78 | |
Device use error, Product dose omission issue, Intentional product use issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, LEVOTHYROXINE SODIUM, |
||||
| 86 | 26941969 |
JP |
53 | 2 |
Physical deconditioning, Dehydration, Renal impairment, Feeding disorder, Product dose omission issue, Off label use, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 87 | 26942031 |
US |
2 | |
Memory impairment, Product dose omission issue, |
||||
ABALOPARATIDE, |
||||
| 88 | 26942041 |
US |
67 | 2 |
Product dose omission issue, Product use issue, Product supply issue, |
||||
ABALOPARATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 89 | 26942186 |
CA |
20 | |
Rectal haemorrhage, Condition aggravated, Frequent bowel movements, Weight decreased, Weight increased, Off label use, Product dose omission issue, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 90 | 26942190 |
US |
||
Product dose omission issue, Device malfunction, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 91 | 26942193 |
US |
72 | 2 |
Weight decreased, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 92 | 26942215 |
US |
||
Syringe issue, Product dose omission issue, |
||||
GUSELKUMAB, |
||||
| 93 | 26942242 |
US |
||
Product dose omission issue, Device delivery system issue, |
||||
| 94 | 26942334 |
GB |
78 | 2 |
Rectal haemorrhage, Product dose omission issue, |
||||
BENRALIZUMAB, BENRALIZUMAB, |
||||
| 95 | 26942357 |
CA |
2 | |
Foot fracture, Lung neoplasm malignant, Rib fracture, Fall, Spinal fracture, Sternal fracture, Compression fracture, Body height decreased, Product dose omission issue, |
||||
DENOSUMAB, DENOSUMAB, |
||||
| 96 | 26942381 |
US |
1 | |
Product dose omission issue, Psychiatric decompensation, |
||||
| 97 | 26942394 |
US |
2 | |
Infection, Product dose omission issue, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE, |
||||
| 98 | 26942402 |
US |
71 | |
Malaise, Device use error, Product dose omission issue, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, |
||||
| 99 | 26942437 |
US |
71 | 1 |
Product dose omission issue, |
||||
DUPILUMAB, |
||||
| 100 | 26942501 |
CN |
44 | 2 |
Needle issue, Product dose omission issue, Off label use, |
||||
GUSELKUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
